Holly Sheffield

Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.

Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA.

Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA.

Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO.

Instylla, Inc. operates as a biotechnology company. Its focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. The company was founded by Amarpreet Sawhney and is headquartered in Waltham, MA.

Research Instruments Ltd. manufactures micropositioners for the semiconductor industry. Its products include IVF thermometer, pH meter 3, VOC meter, particle counter, RI Pipettes, EZ-Tip, EZ-Grip, EZ-Squeeze, EZ-Strip, Fertisafe Plus, Fertisafe, RI MSC, Integra 3, Saturn 5, RI IMSI, and syringes. The company was founded in 1962 and is headquartered in Falmouth, the United Kingdom.

Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC.

LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California.

GestVision, Inc. provides care diagnostic test for preeclampsia. The firm delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. It is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Groton, CT.

Part of Boston Scientific Corp., Quanam Medical Corp develops medical devices using novel polymer technology. The company is based in Santa Clara, CA. Quanam Medical was acquired by Boston Scientific Corp. on April 02, 2001 for $390 million.

Incisive Surgical, Inc. engages in the development of mechanical surgical solutions for skin closure. The firm's product INSORB-20 Subcuticular Skin Stapler is a skin closure device designed to combine the cosmetic result of absorbable sutures with the rapid closure times associated with metal skin staplers and eliminate the need to remove metal staples post-operatively. The company founded in 1999 and is headquartered in Trumbull, CT.

OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel.

Escala Medical Ltd. develops medical devices. It offers a repair device for the treatment of pelvic organ prolapse based on a nonsurgical, incision-free, and mesh-free repair approach. The company was founded by Chen Barak in December 2014 and is headquartered in Misgav, Israel.

May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Twelve, Inc. is a holding company, which engages in the operation as an investment fund for a medical device incubator. It specializes on funding and developing medical device inventions. The company focuses on medical and biotech ventures. The company was founded in 2009 and is headquartered in Redwood City, CA.

Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Qlt Plug Delivery, Inc. provides ocular punctual plug drug delivery system. Its product is used in the treatment of glaucoma. The company was founded by Henry A. Plain Jr. and is headquartered in Menlo Park, CA.

Transcend, Inc. provides training, consulting, and investigation services. The private company is based in Honolulu, HI. Plain. The company was founded by Henry A.

Earlens Corp. develops medical devices. It offers EarLens Contact Hearing Device that uses light to transmit sound. Its earlens contact hearing device two components: a tympanic membrane transducer, which is nonsurgically placed deep in the ear canal on the eardrum, and a light-based behind-the-ear sound processor placed at the base of the ear canal. The company was founded in 1999 by Rodney C. Perkins and is headquartered in Menlo Park, CA.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

HealthCor Management LP (HealthCor) is a holding firm and SEC-registered hedge fund manager headquartered in New York City. The firm was co-founded by Joseph Healey and Arthur Cohen in 2005. HealthCor provides investment management services to several privately offered pooled investment funds and institutional investors through separately managed accounts.